
Cat. #156386
Anti-GST
Cat. #: 156386
Unit size: 100 ug
Availability: 10-12 weeks
Target: Schistosoma mansoni recombinant 28-kDa glutathione S-transferase (Sm28GST)
Class: Polyclonal
Application: WB ; FACS ; ELISA
Reactivity: Schistosoma mansoni
Host: Rabbit
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: University of Illinois Chicago
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-GST
- Alternate name: GST
- Research fields: Immunology;Microbiology
- Class: Polyclonal
- Conjugation: Unconjugated
- Reactivity: Schistosoma mansoni
- Host: Rabbit
- Application: WB ; FACS ; ELISA
- Description: World Health Organization has recommended smGST as one of the candidate vaccine antigens for immunization against S. mansoni. Phage-displayed Sm28GST (pdGST) is immunoreactive and is recognized by immune sera, suggesting that Sm28GST protein displayed on the surface of phages potentially maintains native conformation.
- Immunogen: Glutathione S-transferase
Target Details
- Target: Schistosoma mansoni recombinant 28-kDa glutathione S-transferase (Sm28GST)
- Target background: World Health Organization has recommended smGST as one of the candidate vaccine antigens for immunization against S. mansoni. Phage-displayed Sm28GST (pdGST) is immunoreactive and is recognized by immune sera, suggesting that Sm28GST protein displayed on the surface of phages potentially maintains native conformation.
Applications
- Application: WB ; FACS ; ELISA
Handling
- Format: Liquid
- Unit size: 100 ug
- Shipping conditions: Dry ice
References
- Rao et al. 2003. Clin Diagn Lab Immunol. 10(4):536-41. PMID: 12853382.

![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

